The class of chemicals known as AP-4ε Inhibitors includes compounds that influence cellular processes and signaling pathways associated with the function of the AP-4 complex, of which AP-4ε is a part. These chemicals exert their effects through various mechanisms that can impact the intracellular trafficking and vesicular transport operations in which AP-4ε plays a crucial role. The AP-4 complex is involved in the sorting of proteins to endosomes and lysosomes, and any disruption in the pathways that regulate these processes can affect the function of AP-4ε.
The chemicals listed in the table affect various aspects of cellular function, including Golgi apparatus dynamics, microtubule stability, actin cytoskeleton integrity, vesicle scission, motor protein activity, Rho GTPase signaling, phosphoinositide metabolism, and kinase activity. Each of these aspects plays a role in vesicular trafficking and membrane organization, processes that are fundamental to the proper functioning of AP-4ε. By altering the structure and function of the Golgi, brefeldin A and monensin can affect the formation and transport of vesicles, which are key steps in AP-4ε-mediated trafficking. The integrity and dynamics of the cytoskeleton are essential for vesicular movement, and chemicals like nocodazole, paclitaxel, cytochalasin D, latrunculin A, and blebbistatin can influence these factors, thereby potentially impacting AP-4ε function. Dynasore's inhibition of dynamin can affect endocytic trafficking, while ML-141's inhibition of Cdc42 can affect cytoskeletal organization and vesicular trafficking. Wortmannin's inhibition of PI3K can alter signaling pathways critical for membrane trafficking.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts Golgi structure and function, which can affect AP-4ε-mediated trafficking by altering vesicle formation and transport. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Ionophore that disrupts Golgi function, potentially affecting AP-4ε-dependent vesicular trafficking by altering ion gradients and pH. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Destabilizes microtubules, which can disrupt cytoskeletal dynamics and vesicle transport processes involving AP-4ε. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules and can indirectly affect AP-4ε function by altering microtubule dynamics and vesicle trafficking. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Inhibits dynamin, which can indirectly affect AP-4ε-dependent endocytic trafficking by blocking vesicle scission from the membrane. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Disrupts actin filaments, potentially affecting AP-4ε-mediated trafficking by altering cytoskeletal organization and vesicle movement. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Binds to actin monomers and inhibits polymerization, which can impact AP-4ε-dependent trafficking by disrupting actin cytoskeleton dynamics. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Inhibits myosin II, potentially affecting AP-4ε function in vesicle transport by altering motor protein-driven vesicle motility. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, potentially affecting AP-4ε function by altering phosphoinositide signaling involved in membrane trafficking. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Blocks clathrin-mediated endocytosis, which can indirectly affect AP-4ε function by altering the endocytic pathway and vesicle formation. | ||||||